The overexpression of TRO may be associated with a poor prognosis[52] and the expression level of F13A1 in B-ALL can be a prognostic factor.[53] Notably, ncRNA AJ006998.2 showed subtype-specific expression in the ZNF384 Group (Figure 6L). The gene discussed is TRO; the disease is acute lymphoblastic leukemia.